Meeting of the Advisory Commission on Childhood Vaccines, 59836 [2019-24166]

Download as PDF 59836 Federal Register / Vol. 84, No. 215 / Wednesday, November 6, 2019 / Notices factsheets/primary/pcwork1/index.html. Dated: October 22, 2019. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2019–24229 Filed 11–5–19; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Meeting of the Advisory Commission on Childhood Vaccines Health Resources and Services Administration (HRSA), HHS. ACTION: Notice; correction. AGENCY: The original Federal Register Notice announcing the December 2019 Advisory Commission on Childhood Vaccines (ACCV) meeting indicated that this meeting would be held December 5–6, 2019. This meeting is not being conducted over two days, and instead will only take place only on December 5, 2019. The ACCV will hold a public meeting on December 5, 2019, at 10:00 a.m. Eastern Time via Adobe Connect and telephone conference. This will not be an in-person meeting. The public can join the meeting by: 1. (Audio Portion) Calling the conference phone number: 800–988– 0218 and providing the following information: Leader Name: Ms. Tamara Overby Password: 9302948 (Visual Portion) Connecting to the ACCV Adobe Connect Meeting using the following URL: https:// hrsa.connectsolutions.com/accv/. Participants should call and connect 15 minutes prior to the meeting in order for logistics to be set up. If you have never attended an Adobe Connect meeting, please test your connection using the following URL: https://hrsa.connect solutions.com/common/help/en/ support/meeting_test.htm and get a quick overview using URL: http:// www.adobe.com/go/connectpro_ overview. Information about the ACCV and the agenda for this public meeting can be obtained at the following website: http://www.hrsa.gov/advisory committees/childhoodvaccines/index. html. SUMMARY: FOR FURTHER INFORMATION CONTACT: Annie Herzog, Program Analyst, Division of Injury Compensation Programs (DICP), HRSA, in one of three ways: (1) Send a request to the following VerDate Sep<11>2014 17:43 Nov 05, 2019 Jkt 250001 address: Annie Herzog, Program Analyst, DICP, HRSA, 5600 Fishers Lane, 08N146B, Rockville, Maryland 20857; (2) call (301) 443–6593; or (3) send an email to aherzog@hrsa.gov. Meeting times could change. For the latest information regarding the meeting, including start time, please check the ACCV website at: http:// www.hrsa.gov/advisorycommittees/ childhoodvaccines/index.html. This meeting will only take place on December 5, 2019 and is not being conducted over two days (December 5– 6, 2019) as stated previously in the Federal Register (FR Doc. 2019–00439 Filed 1–30–19). Maria G. Button, Director, Executive Secretariat. [FR Doc. 2019–24166 Filed 11–5–19; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Proposed Collection; Comment Request In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 concerning opportunity for public comment on proposed collections of information, the Substance Abuse and Mental Health Services Administration will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the information collection plans, call the SAMHSA Reports Clearance Officer on (240) 276–1243. Comments are invited on: (a) Whether the proposed collections of information are necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, through the use of automated collection techniques or other forms of information technology. PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 Proposed Project: Protection and Advocacy for Individuals With Mental Illness (PAIMI) Annual Program Performance Report (OMB No. 0930– 0169)—Extension The Protection and Advocacy for Individuals with Mental Illness (PAIMI) Act at 42 U.S.C. 10801 et seq., authorized funds to the same protection and advocacy (P&A) systems created under the Developmental Disabilities Assistance and Bill of Rights Act of 1975, known as the DD Act (as amended in 2000, 42 U.S.C. 15001 et seq.]. The DD Act supports the Protection and Advocacy for Developmental Disabilities (PADD) Program administered by the Administration on Intellectual and Developmental Disabilities (AIDD) within the Administration on Community Living. AIDD is the lead federal P&A agency. The PAIMI Program supports the same governor-designated P&A systems established under the DD Act by providing legal-based individual and systemic advocacy services to individuals with significant (severe) mental illness (adults) and significant (severe) emotional impairment (children/youth) who are at risk for abuse, neglect and other rights violations while residing in a care or treatment facility. In 2000, the PAIMI Act amendments created a 57th P&A system—the American Indian Consortium (the Navajo and Hopi Tribes in the Four Corners region of the Southwest). The Act, at 42 U.S.C. 10804(d), states that a P&A system may use its allotment to provide representation to individuals with mental illness, as defined by section 42 U.S.C. 10802 (4)(B)(iii) residing in the community, including their own home, only, if the total allotment under this title for any fiscal year is $30 million or more, and in such cases an eligible P&A system must give priority to representing PAIMI-eligible individuals, as defined by 42 U.S.C. 10802(4)(A) and (B)(i). The Children’s Health Act of 2000 (CHA) also referenced the state P&A system authority to obtain information on incidents of seclusion, restraint and related deaths [see, CHA, Part H at 42 U.S.C. 290ii–1]. PAIMI Program formula grants awarded by SAMHSA go directly to each of the 57 governor-designated P&A systems. These systems are located in each of the 50 states, the District of Columbia, the American Indian Consortium, American Samoa, Guam, the Commonwealth of the Northern Mariana Islands, the Commonwealth of Puerto Rico, and the U.S. Virgin Islands. E:\FR\FM\06NON1.SGM 06NON1

Agencies

[Federal Register Volume 84, Number 215 (Wednesday, November 6, 2019)]
[Notices]
[Page 59836]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-24166]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the Advisory Commission on Childhood Vaccines

AGENCY: Health Resources and Services Administration (HRSA), HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The original Federal Register Notice announcing the December 
2019 Advisory Commission on Childhood Vaccines (ACCV) meeting indicated 
that this meeting would be held December 5-6, 2019. This meeting is not 
being conducted over two days, and instead will only take place only on 
December 5, 2019.
    The ACCV will hold a public meeting on December 5, 2019, at 10:00 
a.m. Eastern Time via Adobe Connect and telephone conference. This will 
not be an in-person meeting. The public can join the meeting by:
    1. (Audio Portion) Calling the conference phone number: 800-988-
0218 and providing the following information:

Leader Name: Ms. Tamara Overby
Password: 9302948

    (Visual Portion) Connecting to the ACCV Adobe Connect Meeting using 
the following URL: https://hrsa.connectsolutions.com/accv/. 
Participants should call and connect 15 minutes prior to the meeting in 
order for logistics to be set up. If you have never attended an Adobe 
Connect meeting, please test your connection using the following URL: 
https://hrsa.connectsolutions.com/common/help/en/support/meeting_test.htm and get a quick overview using URL: http://www.adobe.com/go/connectpro_overview.
    Information about the ACCV and the agenda for this public meeting 
can be obtained at the following website: http://www.hrsa.gov/advisorycommittees/childhoodvaccines/index.html.

FOR FURTHER INFORMATION CONTACT: Annie Herzog, Program Analyst, 
Division of Injury Compensation Programs (DICP), HRSA, in one of three 
ways: (1) Send a request to the following address: Annie Herzog, 
Program Analyst, DICP, HRSA, 5600 Fishers Lane, 08N146B, Rockville, 
Maryland 20857; (2) call (301) 443-6593; or (3) send an email to 
[email protected]. Meeting times could change. For the latest 
information regarding the meeting, including start time, please check 
the ACCV website at: http://www.hrsa.gov/advisorycommittees/childhoodvaccines/index.html.
    This meeting will only take place on December 5, 2019 and is not 
being conducted over two days (December 5-6, 2019) as stated previously 
in the Federal Register (FR Doc. 2019-00439 Filed 1-30-19).

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2019-24166 Filed 11-5-19; 8:45 am]
 BILLING CODE 4165-15-P